References
- National Institute of Neurological Disorders and Stroke. Tuberous Sclerosis Fact Sheet. Available at: http://www.ninds.nih.gov/disorders/tuberous_sclerosis/detail_tuberous_sclerosis.htm#107073220 [Last accessed 13 May 2010]
- Tuberous Sclerosis Association, UK. Clinical guidelines for the care of patients with Tuberous Sclerosis Complex: Summary. Available at: http://www.tuberous-sclerosis.org/publications/clinicalguidelinessummary.pdf [Last accessed 12 May 2010]
- Au KS, Williams AT, Gambello MJ, et al. Molecular genetic basis of tuberous sclerosis complex: from bench to bedside. J Child Neurol 2004;19:699-709
- Baskin HJ Jr. The pathogenesis and imaging of the tuberous sclerosis complex. Pediatr Radiol 2008;38:936-52
- Camposano SE, Greenberg E, Kwiatkowski DJ, et al. Distinct clinical characteristics of tuberous sclerosis complex patients with no mutation identified. Ann Hum Genet 2009;73:141-6
- Dabora SL, Jozwiak S, Franz DN, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001;68:64-80
- Hottinger AF, Khakoo Y. Update on the management of familial central nervous system tumor syndromes. Curr Neurol Neurosci Rep 2007;7:200-7
- Stables G, Sheehan-Dare R. The dermatological features of tuberous sclerosis and their treatment. (2000) Fact-Sheet No. 25 of the Tuberous Sclerosis Association. 2000. Available at: http://www.tuberous-sclerosis.org/publications/fs25derm.pdf [Last accessed 12 May 2010]
- Yates JR. Tuberous sclerosis. Eur J Hum Genet 2006;14:1065-73
- Crino PB. The pathophysiology of tuberous sclerosis complex. Epilepsia 2010;51(Suppl 1):27-9
- Farrell CJ, Plotkin SR. Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes. Neurol Clin 2007;25:925-46,viii
- Inoki K, Guan KL. Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment. Hum Mol Genet 2009;18(R1):R94-100
- Chan JA, Zhang H, Roberts PS, et al. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. J Neuropathol Exp Neurol 2004;63:1236-42
- Ess KC. The neurobiology of tuberous sclerosis complex. Semin Pediatr Neurol 2006;13:37-42
- Krueger DA, Franz DN. Current management of tuberous sclerosis complex. Paediatr Drugs 2008;10:299-313
- Sampson JR. Therapeutic targeting of mTOR in tuberous sclerosis. Biochem Soc Trans 2009;37(Pt 1):259-64
- Isaacs H. Perinatal (fetal and neonatal) tuberous sclerosis: a review. Am J Perinatol 2009;26:755-60
- Bonsib SM. Renal cystic diseases and renal neoplasms: a mini-review. Clin J Am Soc Nephrol 2009;4:1998-2007
- Castagnetti M, Vezzu B, Laverda A, et al. Urological counseling and followup in pediatric tuberous sclerosis complex. J Urol 2007;178:2155-9
- de Vries PJ, Hunt A, Bolton PF. The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families. Eur Child Adolesc Psychiatry 2007;16:16-24
- Henske EP, Ewalt DH, Bissler JJ. Tuberous Sclerosis Alliance. Renal manifestations in tuberous sclerosis complex. June 2006. Available at: http://www.tsalliance.org/documents/Renal%20Manifestations%20in%20TSC.pdf [Last accessed 13 May 2010]
- O'Callaghan FJ, Noakes MJ, Martyn CN, et al. An epidemiological study of renal pathology in tuberous sclerosis complex. BJU Int 2004;94:853-7
- Rakowski SK, Winterkorn EB, Paul E, et al. Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int 2006;70:1777-82
- Jozwiak J, Jozwiak S, Oldak M. Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment. Med Res Rev 2006;26:160-80
- Akinci A, Oner O, Guven A, et al. Refractive errors and strabismus in children with tuberous sclerosis: a controlled study. J Pediatr Ophthalmol Strabismus 2009;46:345-8
- Costello LC, Hartman TE, Ryu JH. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc 2000;75:591-4
- Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med 2006;355:1345-56
- Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet 2008;372:657-68
- Hancock E, Osborne J. Lymphangioleiomyomatosis: a review of the literature. Respir Med 2002;96:1-6
- Curatolo P, D'Argenzio L, Cerminara C, et al. Management of epilepsy in tuberous sclerosis complex. Expert Rev Neurother 2008;8:457-67
- Gomez MR, Sampson JR, Whittemore VH. Tuberous Sclerosis Complex, 3rd edn. New York and Oxford: Oxford University Press, 1999
- Leung AK, Robson WL. Tuberous sclerosis complex: a review. J Pediatr Health Care 2007;21:108-14
- Kalantari BN, Salamon N. Neuroimaging of tuberous sclerosis: spectrum of pathologic findings and frontiers in imaging. AJR Am J Roentgenol 2008;190:W304-9
- Goh S, Butler W, Thiele EA. Subependymal giant cell tumors in tuberous sclerosis complex. Neurology 2004;63:1457-61
- Shepherd CW, Beard CM, Gomez MR, et al. Tuberous sclerosis complex in Olmsted County, Minnesota, 1950–1989. Arch Neurol 1991;48:400-1
- Tuberous Sclerosis Association, UK. Subependymal giant cell tumours in tuberous sclerosis complex. 2006. Available at: http://www.tuberous-sclerosis.org/publications/fs26sgct.pdf [Last accessed 12 May 2010]
- de Vries P, Humphrey A, McCartney D, et al. Consensus clinical guidelines for the assessment of cognitive and behavioural problems in Tuberous Sclerosis. Eur Child Adolesc Psychiatry 2005;14:183-90
- de Vries PJ, Gardiner J, Bolton PF. Neuropsychological attention deficits in tuberous sclerosis complex (TSC). Am J Med Genet A 2009;149A:387-95
- Moss J, Howlin P. Autism spectrum disorders in genetic syndromes: implications for diagnosis, intervention and understanding the wider autism spectrum disorder population. J Intellect Disabil Res 2009;53:852-73
- Smalley SL. Autism and tuberous sclerosis. J Autism Dev Disord 1998;28:407-14
- Tuberous Sclerosis Alliance. TSC and autism spectrum disorders. June 2006. Available at: http://www.tsalliance.org/documents/TSC%20and%20Autism%20Spectrum%20Disorders.pdf [Last accessed 12 May 2010]
- Zafeiriou DI, Ververi A, Vargiami E. Childhood autism and associated comorbidities. Brain Dev 2007;29:257-72
- Au KS, Williams AT, Roach ES, et al. Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med 2007;9:88-100
- Mitchell AL, Parisi MA, Sybert VP. Effects of pregnancy on the renal and pulmonary manifestations in women with tuberous sclerosis complex. Genet Med 2003;5:154-60
- Nelson CP, Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma. J Urol 2002;168(4 Pt 1):1315-25
- Bader RS, Chitayat D, Kelly E, et al. Fetal rhabdomyoma: prenatal diagnosis, clinical outcome, and incidence of associated tuberous sclerosis complex. J Pediatr 2003;143:620-4
- Di Liang C, Ko SF, Huang SC. Echocardiographic evaluation of cardiac rhabdomyoma in infants and children. J Clin Ultrasound 2000;28:381-6
- Chao AS, Chao A, Wang TH, et al. Outcome of antenatally diagnosed cardiac rhabdomyoma: case series and a meta-analysis. Ultrasound Obstet Gynecol 2008;31:289-95
- Hancock E, Tomkins S, Sampson J, et al. Lymphangioleiomyomatosis and tuberous sclerosis. Respir Med 2002;96:7-13
- Rowley SA, O'Callaghan FJ, Osborne JP. Ophthalmic manifestations of tuberous sclerosis: a population based study. Br J Ophthalmol 2001;85:420-3
- Hohman DW, Noghrehkar D, Ratnayake S. Lymphangioleiomyomatosis: a review. Eur J Intern Med 2008;19:319-24
- Moss J, Avila NA, Barnes PM, et al. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med 2001;164:669-71
- Muzykewicz DA, Newberry P, Danforth N, et al. Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex. Epilepsy Behav 2007;11:506-13
- Franz DN, Brody A, Meyer C, et al. Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med 2001;164:661-8
- Devlin LA, Shepherd CH, Crawford H, et al. Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern Ireland. Dev Med Child Neurol 2006;48:495-9
- Hong CH, Darling TN, Lee CH. Prevalence of tuberous sclerosis complex in Taiwan: a national population-based study. Neuroepidemiology 2009;33:335-41
- Anlauf M, Garbrecht N, Bauersfeld J, et al. Hereditary neuroendocrine tumors of the gastroenteropancreatic system. Virchows Arch 2007;451(Suppl 1):S29-38
- Holmes GL, Stafstrom CE. Tuberous sclerosis complex and epilepsy: recent developments and future challenges. Epilepsia 2007;48:617-30
- Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci 1991;615:125-7
- O'Callaghan FJ. Tuberous sclerosis. BMJ 1999;318:1019-20
- Wong V. Study of the relationship between tuberous sclerosis complex and autistic disorder. J Child Neurol 2006;21:199-204
- Ohtsuka Y, Yoshinaga H, Kobayashi K. Refractory childhood epilepsy and factors related to refractoriness. Epilepsia 2000;41(Suppl 9):14-17
- Raznahan A, Higgins NP, Griffiths PD, et al. Biological markers of intellectual disability in tuberous sclerosis. Psychol Med 2007;37:1293-304
- Raznahan A, Joinson C, O'Callaghan F, et al. Psychopathology in tuberous sclerosis: an overview and findings in a population-based sample of adults with tuberous sclerosis. J Intellect Disabil Res 2006;50(Pt 8):561-9
- Chu-Shore C, Major P, Montenegro M, et al. Cystic Cortical Tubers are predictive of the development of epilepsy in patients with tuberous sclerosis complex. Epilepsia 2008; (Suppl 0): Abstract 1.174
- Hunt A. Development, behaviour and seizures in 300 cases of tuberous sclerosis. J Intellect Disabil Res 1993;37(Pt 1):41-51
- Gallagher A, Chu-Shore CJ, Montenegro MA, et al. Associations between electroencephalographic and magnetic resonance imaging findings in tuberous sclerosis complex. Epilepsy Res 2009;87:197-202
- Liou HH, Oon PC, Lin HC, et al. Risk factors associated with infantile spasms: a hospital-based case-control study in Taiwan. Epilepsy Res 2001;47:91-8
- Primec ZR, Kopac S, Neubauer D. Epidemiologic features of infantile spasms in Slovenia. Epilepsia 2002;43:183-7
- Riikonen R. Epidemiological data of West syndrome in Finland. Brain Dev 2001;23:539-41
- Adriaensen ME, Schaefer-Prokop CM, Stijnen T, et al. Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature. Eur J Neurol 2009;16:691-6
- O'Callaghan FJ, Martyn CN, Renowden S, et al. Subependymal nodules, giant cell astrocytomas and the tuberous sclerosis complex: a population-based study. Arch Dis Child 2008;93:751-4
- Joinson C, O'Callaghan FJ, Osborne JP, et al. Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med 2003;33:335-44
- D'Agati E, Moavero R, Cerminara C, et al. Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex. J Child Neurol 2009;24:1282-7
- Goh S, Kwiatkowski DJ, Dorer DJ, et al. Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex. Neurology 2005;65:235-8
- Winterkorn EB, Pulsifer MB, Thiele EA. Cognitive prognosis of patients with tuberous sclerosis complex. Neurology 2007;68:62-4
- O'Callaghan FJ, Harris T, Joinson C, et al. The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex. Arch Dis Child 2004;89:530-3
- Bolton PF, Park RJ, Higgins JN, et al. Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain 2002;125(Pt 6):1247-55
- Jeste SS, Sahin M, Bolton P, et al. Characterization of autism in young children with tuberous sclerosis complex. J Child Neurol 2008;23:520-5
- Humphrey A, Williams J, Pinto E, et al. A prospective longitudinal study of early cognitive development in tuberous sclerosis – a clinic based study. Eur Child Adolesc Psychiatry 2004;13:159-65
- Australasian Tuberous Sclerosis Society. Clinical guidelines for the care of patients with tuberous sclerosis complex. November 2009. Available at: http://www.atss.org.au/images/stories/clinical%20guidelines%202009.pdf [Last accessed 13 May 2010]
- Wheless JW, Clarke DF, Carpenter D. Treatment of pediatric epilepsy: expert opinion, 2005. J Child Neurol 2005;20(Suppl 1):S1-56; quiz S9-60
- Wheless JW, Clarke DF, Arzimanoglou A, et al. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord 2007;9:353-412
- Hyman MH, Whittemore VH. National Institutes of Health consensus conference: tuberous sclerosis complex. Arch Neurol 2000;57:662-5
- Anisya-Vasanth AV, Satishchandra P, Nagaraja D, et al. Spectrum of epilepsy in tuberous sclerosis. Neurol India 2004;52:210-12
- Sooriakumaran P, Gibbs P, Coughlin G, et al. Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated. BJU Int 2009;105(1):101-6
- Humphrey A, Ploubidis GB, Yates JR, et al. The Early Childhood Epilepsy Severity Scale (E-Chess). Epilepsy Res 2008;79:139-45
- Bollo RJ, Kalhorn SP, Carlson C, et al. Epilepsy surgery and tuberous sclerosis complex: special considerations. Neurosurg Focus 2008;25:E13
- Connolly MB, Hendson G, Steinbok P. Tuberous sclerosis complex: a review of the management of epilepsy with emphasis on surgical aspects. Childs Nerv Syst 2006;22:896-908
- Hottinger AF, Khakoo Y. Neurooncology of familial cancer syndromes. J Child Neurol 2009;24:1526-35
- Jansen FE, van Huffelen AC, Algra A, et al. Epilepsy surgery in tuberous sclerosis: a systematic review. Epilepsia 2007;48:1477-84
- Jarrar RG, Buchhalter JR, Raffel C. Long-term outcome of epilepsy surgery in patients with tuberous sclerosis. Neurology 2004;62:479-81
- Koh S, Jayakar P, Dunoyer C, et al. Epilepsy surgery in children with tuberous sclerosis complex: presurgical evaluation and outcome. Epilepsia 2000;41:1206-13
- Landry CS, Waguespack SG, Perrier ND. Surgical management of nonmultiple endocrine neoplasia endocrinopathies: state-of-the-art review. Surg Clin North Am 2009;89:1069-89
- Luat AF, Makki M, Chugani HT. Neuroimaging in tuberous sclerosis complex. Curr Opin Neurol 2007;20:142-50
- Madhavan D, Schaffer S, Yankovsky A, et al. Surgical outcome in tuberous sclerosis complex: a multicenter survey. Epilepsia 2007;48:1625-8
- Mennel S, Meyer CH, Peter S, et al. Current treatment modalities for exudative retinal hamartomas secondary to tuberous sclerosis: review of the literature. Acta Ophthalmol Scand 2007;85:127-32
- Papadavid E, Markey A, Bellaney G, et al. Carbon dioxide and pulsed dye laser treatment of angiofibromas in 29 patients with tuberous sclerosis. Br J Dermatol 2002;147:337-42
- Shenkman Z, Rockoff MA, Eldredge EA, et al. Anaesthetic management of children with tuberous sclerosis. Paediatr Anaesth 2002;12:700-4
- Teutonico F, Carlson C, LaJoie J, et al. Epilepsy surgery for children with tuberous sclerosis complex and multi-focal EEG findings. Epilepsia 2008; (Suppl 0): Abstract No. 2.297
- Weiner HL, Carlson C, Ridgway EB, et al. Epilepsy surgery in young children with tuberous sclerosis: results of a novel approach. Pediatrics 2006;117:1494-502
- Wu JY, Salamon N, Kirsch HE, et al. Noninvasive testing, early surgery, and seizure freedom in tuberous sclerosis complex. Neurology 2010;74:392-8
- Jansen FE, Van Huffelen AC, Van Rijen PC, et al. Epilepsy surgery in tuberous sclerosis: the Dutch experience. Seizure 2007;16:445-53
- Teutonico F, Mai R, Devinsky O, et al. Epilepsy surgery in tuberous sclerosis complex: early predictive elements and outcome. Childs Nerv Syst 2008;24:1437-45
- Sharma MC, Ralte AM, Gaekwad S, et al. Subependymal giant cell astrocytoma – a clinicopathological study of 23 cases with special emphasis on histogenesis. Pathol Oncol Res 2004;10:219-24
- Cuccia V, Zuccaro G, Sosa F, et al. Subependymal giant cell astrocytoma in children with tuberous sclerosis. Childs Nerv Syst 2003;19:232-43
- Romanelli P, Verdecchia M, Rodas R, et al. Epilepsy surgery for tuberous sclerosis. Pediatr Neurol 2004;31:239-47
- Curatolo P, Bombardieri R, Cerminara C. Current management for epilepsy in tuberous sclerosis complex. Curr Opin Neurol 2006;19:119-23
- Kossoff EH, Thiele EA, Pfeifer HH, et al. Tuberous sclerosis complex and the ketogenic diet. Epilepsia 2005;46:1684-6
- Parain D, Penniello MJ, Berquen P, et al. Vagal nerve stimulation in tuberous sclerosis complex patients. Pediatr Neurol 2001;25:213-16
- Thiele EA. Managing epilepsy in tuberous sclerosis complex. J Child Neurol 2004;19:680-6
- Camposano SE, Major P, Halpern E, et al. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile. Epilepsia 2008;49:1186-91
- Collins JJ, Tudor C, Leonard JM, et al. Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial. J Child Neurol 2006;21:53-7
- Crino PB. Rapamycin and tuberous sclerosis complex: from Easter Island to epilepsy. Ann Neurol 2008;63:415-17
- Ess KC. Tuberous sclerosis complex: a brave new world? Curr Opin Neurol 2010;23:189-93
- Franz DN, Tudor C, Leonard J, et al. Lamotrigine therapy of epilepsy in tuberous sclerosis. Epilepsia 2001;42:935-40
- Hancock E, Osborne JP, Milner P. The treatment of West syndrome: a Cochrane review of the literature to December 2000. Brain Dev 2001;23:624-34
- Jozwiak S, Kotulska K, Domanska-Pakiela D, et al. Treatment of epileptogenic activity on EEG prevents epilepsy and psychomotor delay in children with tuberous sclerosis. Epilepsia 2009; (Suppl 0): Abstract No. 2.091
- Mackay M, Weiss S, Snead OC 3rd. Treatment of infantile spasms: an evidence-based approach. Int Rev Neurobiol 2002;49:157-84
- Mackay MT, Weiss SK, Adams-Webber T, et al. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 2004;62:1668-81
- Malphrus AD, Wilfong AA. Use of the newer antiepileptic drugs in pediatric epilepsies. Curr Treat Options Neurol 2007;9:256-67
- Martignoni G, Pea M, Reghellin D, et al. PEComas: the past, the present and the future. Virchows Arch 2008;452:119-32
- Paghdal KV, Schwartz RA. Sirolimus (rapamycin): from the soil of Easter Island to a bright future. J Am Acad Dermatol 2007;57:1046-50
- Parisi P, Bombardieri R, Curatolo P. Current role of vigabatrin in infantile spasms. Eur J Paediatr Neurol 2007;11:331-6
- Riikonen RS. Steroids or vigabatrin in the treatment of infantile spasms? Pediatr Neurol 2000;23:403-8
- Siroky BJ, Czyzyk-Krzeska MF, Bissler JJ. Renal involvement in tuberous sclerosis complex and von Hippel-Lindau disease: shared disease mechanisms? Nat Clin Pract Nephrol 2009;5:143-56
- Wheless JW, Ramsay RE, Collins SD. Vigabatrin. Neurotherapeutics 2007;4:163-72
- Willmore LJ, Abelson MB, Ben-Menachem E, et al. Vigabatrin: 2008 update. Epilepsia 2009;50:163-73
- Hancock EC, Osborne JP, Edwards SW. Treatment of infantile spasms. Cochrane Database Syst Rev 2008(4):CD001770
- Curatolo P, Seri S, Verdecchia M, et al. Infantile spasms in tuberous sclerosis complex. Brain Dev 2001;23:502-7
- Riikonen R. The latest on infantile spasms. Curr Opin Neurol 2005;18:91-5
- Jiang T, Jia G, Ma Z, et al. The diagnosis and treatment of subependymal giant cell astrocytoma combined with tuberous sclerosis. Childs Nerv Syst 2011;27:55-62
- Galanopoulou A, Crino P, Wong M, et al. Rapamycin: From tuberous sclerosis and beyond. Investigator Workshop No. IW.07 at the 2009 Annual Meeting of the American Epilepsy Society. Epilepsia 2009;50(Suppl s11):309
- Franz DN, Krueger DA, Care MM, et al. Everolimus for subependymal giant-cell astrocytimas (SEGAs) in tuberous sclerosis (TS). J Clin Oncol 2010;28(7s): Abstract No. 2004
- Franz DN, Leonard J, Tudor C, et al. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol 2006;59:490-8
- Krueger DA, Care MM, Holland K, et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 2010;363:1801-11
- U.S. National Institutes of Health. ClinicalTrials.gov. Available at: http://clinicaltrials.gov/ [Last accessed 24 January 2011]. ClinicalTrials.gov is a registry and results database of federally and privately supported clinical trials conducted in the United States and around the world. Searched for trials on Everolimus in TSC. Available at: http://clinicaltrials.gov/ct2/results?term=everolimus+in+TSC
- Torres AR, Whitney J, Gonzalez-Heydrich J. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment. Epilepsy Behav 2008;12:217-33
- Jones AC, Sampson JR, Hoogendoorn B, et al. Application and evaluation of denaturing HPLC for molecular genetic analysis in tuberous sclerosis. Hum Genet 2000;106:663-8
- Steiger HJ. Preventive neurosurgery: population-wide check-up examinations and correction of asymptomatic pathologies of the nervous system. Acta Neurochir (Wien) 2006;148:1075-83;discussion 83
- Valentim J. Long-term disability cost in tuberous sclerosis complex (TSC) in Brazil. Prague, Czech Republic: ISPOR, 2010
- Ferguson AP, McKinlay IA, Hunt A. Care of adolescents with severe learning disability from tuberous sclerosis. Dev Med Child Neurol 2002;44:256-62
- Kopp CM, Muzykewicz DA, Staley BA, et al. Behavior problems in children with tuberous sclerosis complex and parental stress. Epilepsy Behav 2008;13:505-10
- Sabaz M, Lawson JA, Cairns DR, et al. Validation of the quality of life in childhood epilepsy questionnaire in American epilepsy patients. Epilepsy Behav 2003;4:680-91
- Schwartz RA, Fernandez G, Kotulska K, et al. Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J Am Acad Dermatol 2007;57:189-202
- Chu-Shore CJ, Major P, Camposano S, et al. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 2009;51:1236-41
- Tuberous Sclerosis Association UK. Effects of TSC. Available at: http://www.tuberous-sclerosis.org/?page_id=58 [Last accessed 13 May 2010]
- Wienecke R, Fackler I, Linsenmaier U, et al. Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex. Am J Kidney Dis 2006;48:e27-9
- Lantin RL. Tuberous Sclerosis Alliance. Heart manifestations in TSC. June 2006. Available at: http://www.tsalliance.org/documents/Heart%20Manifestations%20in%20TSC.pdf [Last accessed 13 May 2010]
- Kingwood JC. Monitoring kidney problems in tuberous sclerosis. (2001) Fact-sheet No. 21 of the Tuberous Sclerosis Association. 2001. Available at: http://www.tuberous-sclerosis.org/publications/fs24kidney.pdf [Last accessed 13 May 2010]
- TSC Canada. Tuberous Sclerosis Information Page. Available at: http://www.tscanada.ca/tscinfo.htm [Last accessed 13 May 2010]
- Tuberous Sclerosis Association, UK. Clinical guidelines for assessment of behaviour and learning in tuberous sclerosis complex. Available at: http://www.tuberous-sclerosis.org/publications/TSA%20Assess%20of%20Behav%20KD.pdf [Last accessed 12 May 2010]
- Franz DN. Mental Retardation in Tuberous Sclerosis Complex. An informational fact sheet from the Tuberous Sclerosis Alliance. 2006. Available at: http://www.tsalliance.org/documents/Mental%20Retardation%20in%20TSC.pdf [Last accessed 13 May 2010]
- Dunn DW, Kronenberger WG. Tuberous Sclerosis Alliance. Attention deficit hyperactivity disorder and tuberous sclerosis complex. June 2006. Available at: http://www.tsalliance.org/documents/Attention%20Deficit%20Hyperactivity%20Disorder%20and%20TSC.pdf [Last accessed 13 May 2010]
- Wong M. Tuberous Sclerosis Complex: Mysteries, Manifestations, Mechanisms, and Management. Available at: http://neuro.wustl.edu/patientcare/clinicalservices/tuberoussclerosisclinic/tuberoussclerosiscomplex.htm [Last accessed 13 May 2010]
- Tuberous Sclerosis Association, UK. Behaviour in adults with tuberous sclerosis complex. 2009. Available at: http://www.tuberous-sclerosis.org/publications/Behaviour%20in%20adults%20with%20TSC%202009.pdf [Last accessed 12 May 2010]